Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology by mapping the functional relationships between chemicals and human biology to engineer rational ways to improve health and treat disease. Octant is applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest to find safer, more effective, and cheaper drugs. Founded by Ramsey Homsany and Sri Kosuri in 2017, Octant Bio is backed by investors that include 8VC, Allen & Company LLC, Andreessen Horowitz, and SV Angel and is headquartered in Los Angeles.